Pub Date : 2025-11-01Epub Date: 2025-09-02DOI: 10.1177/03915603251370915
Juan Camilo Barrera Cardenas, Philippe E Spiess, Herney Andrés García-Perdomo
Human papillomavirus (HPV) is a prevalent sexually transmitted disease worldwide. Very little is known about the effect of HPV on men's health. It is estimated that it is one of the most critical causes of penile cancer worldwide, representing a considerable percentage of the cases. We aimed to review the information on HPV vaccination strategy plans worldwide and the effect on male genital health. Studies on the outcomes of countries that include males in HPV vaccination programs and what the result will be in those that do not indicate favorable data in terms of preventing disease and thus the cost-effectiveness of gender-neutral HPV vaccination in most high-income countries (HIC) as well as in low-to-middle income countries (LMIC), considering HPV universal vaccination as a public health strategy. Vaccination of men against HPV is an effective strategy to prevent the development of genital cancers in this population.
{"title":"Human papillomavirus vaccination and its effect on genital men's health. Considerations for a public health strategy.","authors":"Juan Camilo Barrera Cardenas, Philippe E Spiess, Herney Andrés García-Perdomo","doi":"10.1177/03915603251370915","DOIUrl":"10.1177/03915603251370915","url":null,"abstract":"<p><p>Human papillomavirus (HPV) is a prevalent sexually transmitted disease worldwide. Very little is known about the effect of HPV on men's health. It is estimated that it is one of the most critical causes of penile cancer worldwide, representing a considerable percentage of the cases. We aimed to review the information on HPV vaccination strategy plans worldwide and the effect on male genital health. Studies on the outcomes of countries that include males in HPV vaccination programs and what the result will be in those that do not indicate favorable data in terms of preventing disease and thus the cost-effectiveness of gender-neutral HPV vaccination in most high-income countries (HIC) as well as in low-to-middle income countries (LMIC), considering HPV universal vaccination as a public health strategy. Vaccination of men against HPV is an effective strategy to prevent the development of genital cancers in this population.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"721-727"},"PeriodicalIF":0.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144970868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To assess the efficacy and safety of lithotripsy with ureteroscopy for managing ureteral stone in octogenarian patients.
Materials and methods: This retrospective study analyzed 314 patients who underwent retrograde lithotripsy with ureteroscopy for ureteral stones between January 2018 and August 2024. Patients were categorized into two groups based on age: the octogenarian group (⩾80 years) and the younger patient group (<80 years). Clinical parameters, including the stone-free rate, postoperative length of hospital stay, and postoperative complications, were compared. To minimize confounding variables, 1:1 propensity score matching was performed, resulting in 41 patients in each group.
Results: After propensity score matching, no significant differences in baseline clinical characteristics between the groups. Additionally, no statistically significant differences were observed in the stone-free rate, postoperative length of hospital stay, or postoperative complication rates between the two cohorts.
Conclusion: These findings suggest that lithotripsy with ureteroscopy is an effective and safe treatment option for ureteral stones in carefully selected octogenarian patients.
{"title":"Efficacy and safety of lithotripsy with ureteroscopy for ureteral stones in octogenarians.","authors":"Ryo Sato, Asuka Uchiyama, Shungo Kakinuma, Rikiya Matsumoto","doi":"10.1177/03915603251343168","DOIUrl":"10.1177/03915603251343168","url":null,"abstract":"<p><strong>Objective: </strong>To assess the efficacy and safety of lithotripsy with ureteroscopy for managing ureteral stone in octogenarian patients.</p><p><strong>Materials and methods: </strong>This retrospective study analyzed 314 patients who underwent retrograde lithotripsy with ureteroscopy for ureteral stones between January 2018 and August 2024. Patients were categorized into two groups based on age: the octogenarian group (⩾80 years) and the younger patient group (<80 years). Clinical parameters, including the stone-free rate, postoperative length of hospital stay, and postoperative complications, were compared. To minimize confounding variables, 1:1 propensity score matching was performed, resulting in 41 patients in each group.</p><p><strong>Results: </strong>After propensity score matching, no significant differences in baseline clinical characteristics between the groups. Additionally, no statistically significant differences were observed in the stone-free rate, postoperative length of hospital stay, or postoperative complication rates between the two cohorts.</p><p><strong>Conclusion: </strong>These findings suggest that lithotripsy with ureteroscopy is an effective and safe treatment option for ureteral stones in carefully selected octogenarian patients.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"643-649"},"PeriodicalIF":0.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144128482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Male urethral stricture is a common clinical condition in urology with significant socioeconomic impacts and is associated with high recurrence rates.Visual internal urethrotomy (VIU) is a widely used endoscopic treatment for short-segment urethral strictures (<2 cm). The aim of this study was to evaluate the stricture-free rates and analyze the predictive factors for recurrence after VIU, following both initial and repeated urethrotomies, with 12 months of follow-up.
Methods: This retrospective study included male patients who underwent VIU for urethral stricture disease between January 2021 and July 2023. Statistical analysis was performed using MedCalc software (version 22.00). Univariate analyses were conducted using the Chi-square test for categorical variables and the t-test for continuous variables.
Results: A total of 132 patients with a mean age of 39.8 years were included in the study, with a follow-up duration of 12 months. The mean stricture length was 12 mm, and the most common site of stricture was the bulbar urethra. The stricture-free rate following the first VIU was 59.7%, with a mean time to recurrence of 6.7 months. After the second VIU, the stricture-free rate decreased to 45.5%, with a mean time to recurrence of 5.2 months. The cumulative stricture-free rate at 12 months (following both first and second VIU) was 80.3%, with a mean time to recurrence of 7.9 months (range: 4-11 months). Patients who experienced recurrence after the second VIU underwent definitive urethroplasty. Intraoperative factors significantly influenced the outcomes of VIU, including stricture length (<2 cm vs >2 cm, p = 0.045), health of the urethral mucosa (healthy vs unhealthy, p = 0.250), presence of spongiofibrosis (present vs absent, p = 0.07), and stricture location (mid-bulbar urethral stricture in 74 patients [56.09%], penobulbar/distal bulbar urethral stricture in 50 patients [37.8%], and bulbomembranous/proximal bulbar urethral stricture in eight patients [6.09%]).
Conclusions: Although VIU is a relatively simple procedure, it yields acceptable outcomes in carefully selected patients. Stricture length and the presence of spongiofibrosis had a statistically significant impact on outcomes. Other independent predictive factors for failure of VIU included older age, obesity, and mucosal health.
导读:男性尿道狭窄是泌尿外科常见的临床疾病,具有显著的社会经济影响,并与高复发率相关。视觉内尿道切开术(VIU)是一种广泛应用于短段尿道狭窄的内镜治疗方法(方法:本回顾性研究纳入了2021年1月至2023年7月期间因尿道狭窄疾病接受VIU治疗的男性患者。采用MedCalc软件(22.00版本)进行统计分析。单因素分析对分类变量采用卡方检验,对连续变量采用t检验。结果:共纳入132例患者,平均年龄39.8岁,随访时间12个月。平均狭窄长度为12 mm,最常见的狭窄部位为尿道球部。首次VIU后无狭窄率为59.7%,平均复发时间为6.7个月。第二次静脉穿刺后,无狭窄率降至45.5%,平均复发时间5.2个月。12个月(第一次和第二次VIU后)累计无狭窄率为80.3%,平均复发时间为7.9个月(范围:4-11个月)。第二次VIU后复发的患者行最终尿道成形术。术中因素包括狭窄长度(2 cm, p = 0.045)、尿道黏膜健康状况(健康vs不健康,p = 0.250)、有无海绵状纤维化(存在vs不存在,p = 0.07)、狭窄位置(74例(56.09%)、50例(37.8%)、8例(6.09%)尿道球中部狭窄。结论:虽然VIU是一个相对简单的手术,但在精心挑选的患者中,它产生了可接受的结果。狭窄长度和海绵状纤维化的存在对结果有统计学上显著的影响。VIU失败的其他独立预测因素包括年龄较大、肥胖和粘膜健康。
{"title":"Outcomes and predictive factors of recurrence after endoscopic management of male bulbar urethral stricture at a Tertiary Care Centre.","authors":"Om Kumar Yadav, Jaydeep Jain, Shiv Charan Navriya, Deepak Prakash Bhirud, Mahendra Singh, Gautam Ram Choudhary, Arjun Singh Sandhu","doi":"10.1177/03915603251351068","DOIUrl":"10.1177/03915603251351068","url":null,"abstract":"<p><strong>Introduction: </strong>Male urethral stricture is a common clinical condition in urology with significant socioeconomic impacts and is associated with high recurrence rates.Visual internal urethrotomy (VIU) is a widely used endoscopic treatment for short-segment urethral strictures (<2 cm). The aim of this study was to evaluate the stricture-free rates and analyze the predictive factors for recurrence after VIU, following both initial and repeated urethrotomies, with 12 months of follow-up.</p><p><strong>Methods: </strong>This retrospective study included male patients who underwent VIU for urethral stricture disease between January 2021 and July 2023. Statistical analysis was performed using MedCalc software (version 22.00). Univariate analyses were conducted using the Chi-square test for categorical variables and the <i>t</i>-test for continuous variables.</p><p><strong>Results: </strong>A total of 132 patients with a mean age of 39.8 years were included in the study, with a follow-up duration of 12 months. The mean stricture length was 12 mm, and the most common site of stricture was the bulbar urethra. The stricture-free rate following the first VIU was 59.7%, with a mean time to recurrence of 6.7 months. After the second VIU, the stricture-free rate decreased to 45.5%, with a mean time to recurrence of 5.2 months. The cumulative stricture-free rate at 12 months (following both first and second VIU) was 80.3%, with a mean time to recurrence of 7.9 months (range: 4-11 months). Patients who experienced recurrence after the second VIU underwent definitive urethroplasty. Intraoperative factors significantly influenced the outcomes of VIU, including stricture length (<2 cm vs >2 cm, <i>p</i> = 0.045), health of the urethral mucosa (healthy vs unhealthy, <i>p</i> = 0.250), presence of spongiofibrosis (present vs absent, <i>p</i> = 0.07), and stricture location (mid-bulbar urethral stricture in 74 patients [56.09%], penobulbar/distal bulbar urethral stricture in 50 patients [37.8%], and bulbomembranous/proximal bulbar urethral stricture in eight patients [6.09%]).</p><p><strong>Conclusions: </strong>Although VIU is a relatively simple procedure, it yields acceptable outcomes in carefully selected patients. Stricture length and the presence of spongiofibrosis had a statistically significant impact on outcomes. Other independent predictive factors for failure of VIU included older age, obesity, and mucosal health.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"686-692"},"PeriodicalIF":0.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144754428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-08-06DOI: 10.1177/03915603251358961
Saima Naz Akhtar, Gigja Gudbrandsdottir, Erling Aarsæther, Birgitte Carlsen, Magne Dimmen, Ingrid Hannestad, Erik Skaaheim Haug, Olav Andreas Hopland, Ann-Karoline Karlsvik, Eirik Kjøbli, Stig Müller, Christian Arvei Moen, Patrick Juliebø-Jones, Christian Beisland
Background and objective: This study aims to map the prevalence and treatment of urachal cancer (UrC) in Norway, establish survival rates, identify prognostic factors, and evaluate whether any of the three commonly used staging systems for UrC provide superior prognostic value.
Methods: In this retrospective cohort study, data from the National Cancer Register was collected to identify patients diagnosed with UrC between1997 and2022. Eligible cases (n = 43) underwent retrospective review of their individual hospital records. All patients were staged using the Sheldon, Mayo, and Limonnik-revised TNM systems. This was performed locally and then checked by the coordinating center.Key findings and limitations:The median age at surgery was 59.5 years (IQR 49-73), with 57% of patients being male. The median follow-up time for survivors was 98 months (IQR 81-153). Macroscopic hematuria was the most common presentation (67%, n = 28). Recurrence-free survival (RFS) rates at 1, 3, and 5 years were 71%, 57%, and 53%, respectively. Cancer specific survival (CSS) was 95%, 62%, 55%, and overall survival (OS) rates were 93%, 61%, 46% at the same time points. Smaller tumor size was an independent predictor of improved CSS (HR 1.3, CI: 1.01-1.6, p = 0.045). Of the three staging systems, only the Mayo system showed statistically significant differences between stages for OS, while none of the systems, including Mayo, showed significant differences for CSS. Study limitations include a small sample size and a prolonged study period of 25 years, which may affect the generalizability of the findings and introduce bias due to changes in clinical practice over time, such as advancements in surgical techniques, and oncological therapies.
Conclusions and clinical implications: Urachal cancer is frequently diagnosed at an advanced stage. Our findings suggest that the Mayo system more effectively distinguishes between localized, locally advanced, and advanced disease compared to the Sheldon and Limonnik-revised TNM systems.
{"title":"Presentation and survival for urachal cancer: Findings from a nationwide multicenter cohort study in Norway.","authors":"Saima Naz Akhtar, Gigja Gudbrandsdottir, Erling Aarsæther, Birgitte Carlsen, Magne Dimmen, Ingrid Hannestad, Erik Skaaheim Haug, Olav Andreas Hopland, Ann-Karoline Karlsvik, Eirik Kjøbli, Stig Müller, Christian Arvei Moen, Patrick Juliebø-Jones, Christian Beisland","doi":"10.1177/03915603251358961","DOIUrl":"10.1177/03915603251358961","url":null,"abstract":"<p><strong>Background and objective: </strong>This study aims to map the prevalence and treatment of urachal cancer (UrC) in Norway, establish survival rates, identify prognostic factors, and evaluate whether any of the three commonly used staging systems for UrC provide superior prognostic value.</p><p><strong>Methods: </strong>In this retrospective cohort study, data from the National Cancer Register was collected to identify patients diagnosed with UrC between1997 and2022. Eligible cases (<i>n</i> = 43) underwent retrospective review of their individual hospital records. All patients were staged using the Sheldon, Mayo, and Limonnik-revised TNM systems. This was performed locally and then checked by the coordinating center.Key findings and limitations:The median age at surgery was 59.5 years (IQR 49-73), with 57% of patients being male. The median follow-up time for survivors was 98 months (IQR 81-153). Macroscopic hematuria was the most common presentation (67%, <i>n</i> = 28). Recurrence-free survival (RFS) rates at 1, 3, and 5 years were 71%, 57%, and 53%, respectively. Cancer specific survival (CSS) was 95%, 62%, 55%, and overall survival (OS) rates were 93%, 61%, 46% at the same time points. Smaller tumor size was an independent predictor of improved CSS (HR 1.3, CI: 1.01-1.6, <i>p</i> = 0.045). Of the three staging systems, only the Mayo system showed statistically significant differences between stages for OS, while none of the systems, including Mayo, showed significant differences for CSS. Study limitations include a small sample size and a prolonged study period of 25 years, which may affect the generalizability of the findings and introduce bias due to changes in clinical practice over time, such as advancements in surgical techniques, and oncological therapies.</p><p><strong>Conclusions and clinical implications: </strong>Urachal cancer is frequently diagnosed at an advanced stage. Our findings suggest that the Mayo system more effectively distinguishes between localized, locally advanced, and advanced disease compared to the Sheldon and Limonnik-revised TNM systems.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"595-602"},"PeriodicalIF":0.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12572362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-07-07DOI: 10.1177/03915603251351069
Hossam Mohamed Hafez Elawady, Wael Ali Maged, Mostafa Mabrouk Bayoumi Aly Wahba, Ahmed Tawfick Hassan, Mahmoud Ahmed Mahmoud
Background: This study assessed the safety and efficacy of management strategies for residual upper calyceal stones (1-2 cm) following percutaneous nephrolithotomy for staghorn calculi, comparing conservative management to interventional approaches.
Methods: A randomized trial included 105 patients with residual stones, assigned to flexible ureterorenoscopic laser lithotripsy (Group A), extracorporeal shock wave lithotripsy (ESWL, Group B), or conservative management (Group C). Outcomes included the need for additional interventions, stone-free rates, complications, and cost-effectiveness. Patients were followed for 1 year to assess pain, hematuria, hospital readmission, and stone clearance.
Results: Conservative management led to a 20% intervention rate within a year, primarily due to pain, obstruction, or patient preference. A stone size ⩽ 1.4 cm predicted the likelihood of intervention. Flexible ureterorenoscopy had the highest stone-free rate (94.29%), followed by ESWL (71.43%, p = 0.023). ESWL was the most cost-effective option (10.17 × 10³ vs 39.47 × 10³ Egyptian pounds, p < 0.001) but was less effective for high-density stones.
Conclusions: While conservative management avoids immediate intervention, it carries a higher risk of future complications and delayed interventions. Early intervention with flexible ureterorenoscopy or ESWL offers better long-term outcomes, with ESWL being the most cost-effective option.
{"title":"Modalities of management of residual upper calyceal stones after percutaneous nephrolithotomy for staghorn stone: A randomized controlled trial.","authors":"Hossam Mohamed Hafez Elawady, Wael Ali Maged, Mostafa Mabrouk Bayoumi Aly Wahba, Ahmed Tawfick Hassan, Mahmoud Ahmed Mahmoud","doi":"10.1177/03915603251351069","DOIUrl":"10.1177/03915603251351069","url":null,"abstract":"<p><strong>Background: </strong>This study assessed the safety and efficacy of management strategies for residual upper calyceal stones (1-2 cm) following percutaneous nephrolithotomy for staghorn calculi, comparing conservative management to interventional approaches.</p><p><strong>Methods: </strong>A randomized trial included 105 patients with residual stones, assigned to flexible ureterorenoscopic laser lithotripsy (Group A), extracorporeal shock wave lithotripsy (ESWL, Group B), or conservative management (Group C). Outcomes included the need for additional interventions, stone-free rates, complications, and cost-effectiveness. Patients were followed for 1 year to assess pain, hematuria, hospital readmission, and stone clearance.</p><p><strong>Results: </strong>Conservative management led to a 20% intervention rate within a year, primarily due to pain, obstruction, or patient preference. A stone size ⩽ 1.4 cm predicted the likelihood of intervention. Flexible ureterorenoscopy had the highest stone-free rate (94.29%), followed by ESWL (71.43%, <i>p</i> = 0.023). ESWL was the most cost-effective option (10.17 × 10³ vs 39.47 × 10³ Egyptian pounds, <i>p</i> < 0.001) but was less effective for high-density stones.</p><p><strong>Conclusions: </strong>While conservative management avoids immediate intervention, it carries a higher risk of future complications and delayed interventions. Early intervention with flexible ureterorenoscopy or ESWL offers better long-term outcomes, with ESWL being the most cost-effective option.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"663-669"},"PeriodicalIF":0.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144576415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-08-17DOI: 10.1177/03915603251355819
Anupam Choudhary, A V B Krishnakanth, K R Surag, Ankit Agarwal, Abhijit Shah, Kasi Viswanath Gali, Padmaraj Hegde
Introduction: Various nephrolithometry scoring systems have been introduced to assess the outcomes of percutaneous nephrolithotomy (PCNL) and postoperative complications. Previous studies have incorporated various variables to determine factors influencing postoperative acute kidney injury (AKI). Using separate scoring systems or nomograms to predict postoperative outcomes and AKI is cumbersome. Our study aims to find if stone scoring systems can be used to predict AKI following a PCNL procedure.
Materials and methods: A prospective observational study was conducted at Kasturba Hospital and Medical College from December 2023 to June 2024. All patients undergoing PCNL were included in the study. Scores were calculated for all patients pre-operatively using various nephrolithometry scoring systems. Patients were divided into two groups based on the presence or absence of AKI following PCNL. The various stone scoring systems were assessed for their ability to predict AKI following PCNL.
Results: Out of the 90 patients in the study, 15 (16.66%) developed AKI, and 75 (83.33%) had no AKI following PCNL. Statistical significance was found in stone size (p < 0.001), stone location (p = 0.011), Staghorn (p < 0.001), Guy's Score (p = 0.001), STONE score (0.002), CROES Score (p = 0.001), Amplatz size (p = 0.012) and energy source (p = 0.01). No statistical significance was found when comparing sex, comorbidities, number of stones, the severity of HN, puncture location and number, intraoperative hypotension, operative time, and duration of hospital stay.
Conclusion: Nephrolithometry scoring systems, in addition to assessing postoperative outcomes such as stone-free rate and complications, can also be used to predict the occurrence of AKI. The use of a limited number of scoring systems to assess all the postoperative outcomes will help simplify and facilitate their use in routine clinical practice.
导读:各种肾结石测量评分系统被用于评估经皮肾镜取石术(PCNL)的预后和术后并发症。以往的研究纳入了各种变量来确定影响术后急性肾损伤(AKI)的因素。使用单独的评分系统或图来预测术后结果和AKI是很麻烦的。我们的研究旨在发现结石评分系统是否可以用于预测PCNL手术后的AKI。材料和方法:于2023年12月至2024年6月在卡斯图尔巴医院和医学院进行了一项前瞻性观察研究。所有接受PCNL的患者都被纳入研究。术前使用各种肾结石测量评分系统计算所有患者的评分。根据PCNL后AKI的存在与否将患者分为两组。评估各种结石评分系统预测PCNL后AKI的能力。结果:90例患者中,15例(16.66%)发生了AKI, 75例(83.33%)在PCNL术后无AKI。结石大小(p p = 0.011)、Staghorn评分(p p = 0.001)、stone评分(0.002)、CROES评分(p = 0.001)、Amplatz评分(p = 0.012)、能量来源(p = 0.01)均有统计学意义。性别、合并症、结石数量、HN严重程度、穿刺部位及次数、术中低血压、手术时间、住院时间比较,差异无统计学意义。结论:肾结石计分系统除了评估术后无结石率和并发症等预后外,还可用于预测AKI的发生。使用有限数量的评分系统来评估所有术后结果将有助于简化和促进其在常规临床实践中的使用。
{"title":"Nephrolithometry scoring systems in predicting acute kidney injury following percutaneous nephrolithotomy - A prospective observational study.","authors":"Anupam Choudhary, A V B Krishnakanth, K R Surag, Ankit Agarwal, Abhijit Shah, Kasi Viswanath Gali, Padmaraj Hegde","doi":"10.1177/03915603251355819","DOIUrl":"10.1177/03915603251355819","url":null,"abstract":"<p><strong>Introduction: </strong>Various nephrolithometry scoring systems have been introduced to assess the outcomes of percutaneous nephrolithotomy (PCNL) and postoperative complications. Previous studies have incorporated various variables to determine factors influencing postoperative acute kidney injury (AKI). Using separate scoring systems or nomograms to predict postoperative outcomes and AKI is cumbersome. Our study aims to find if stone scoring systems can be used to predict AKI following a PCNL procedure.</p><p><strong>Materials and methods: </strong>A prospective observational study was conducted at Kasturba Hospital and Medical College from December 2023 to June 2024. All patients undergoing PCNL were included in the study. Scores were calculated for all patients pre-operatively using various nephrolithometry scoring systems. Patients were divided into two groups based on the presence or absence of AKI following PCNL. The various stone scoring systems were assessed for their ability to predict AKI following PCNL.</p><p><strong>Results: </strong>Out of the 90 patients in the study, 15 (16.66%) developed AKI, and 75 (83.33%) had no AKI following PCNL. Statistical significance was found in stone size (<i>p</i> < 0.001), stone location (<i>p</i> = 0.011), Staghorn (<i>p</i> < 0.001), Guy's Score (<i>p</i> = 0.001), STONE score (0.002), CROES Score (<i>p</i> = 0.001), Amplatz size (<i>p</i> = 0.012) and energy source (<i>p</i> = 0.01). No statistical significance was found when comparing sex, comorbidities, number of stones, the severity of HN, puncture location and number, intraoperative hypotension, operative time, and duration of hospital stay.</p><p><strong>Conclusion: </strong>Nephrolithometry scoring systems, in addition to assessing postoperative outcomes such as stone-free rate and complications, can also be used to predict the occurrence of AKI. The use of a limited number of scoring systems to assess all the postoperative outcomes will help simplify and facilitate their use in routine clinical practice.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"705-712"},"PeriodicalIF":0.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144862510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To compare the efficacy and safety of mini-percutaneous nephrolithotomy versus flexible ureteroscopy with laser lithotripsy in the management of calyceal diverticulum stones.
Methods: The study performed a prospective analysis of 91 patients with confirmed calyceal diverticulum stones in Saudi Arabia from January 2020 to June 2024. A total of 78 patients with CD (calyceal diverticulum) stones were randomly divided into two groups: Group A (n = 39) FURSL and Group B (n = 39) mini-PCNL. The study analyzed patient demographics, stone complexity, operative parameters, postoperative results, and postoperative outcomes, including stone-free rates, operative time, hospital stay, complication rates, and recovery time.
Results: Both groups showed similar baseline characteristics and surgical feasibility, with the mini-PCNL group showing a higher SFR (84.62% vs 71.79%), but not statistically significant. Hospital stay was significantly shorter in the FURSL group (17.31 ± 3.06 h vs 30.03 ± 7.18 h; p < 0.001). Patients undergoing FURSL returned to normal activity sooner (5.1 ± 1.37 days vs 8.03 ± 1.05 days; p < 0.05). Complication rates were low and nearly similar across groups.
Conclusions: Both mini-PCNL and FURSL are effective strategies for treating calyceal diverticulum stones. Notably, mini-PCNL offers superior stone-free rates, while FURSL offers shorter operative times, hospital stays, and fast recovery.
目的:比较微型经皮肾镜取石术与输尿管软镜联合激光碎石术治疗肾盏憩室结石的疗效和安全性。方法:本研究对沙特阿拉伯2020年1月至2024年6月确诊的91例肾盏憩室结石患者进行了前瞻性分析。78例肾盏憩室结石患者随机分为两组:A组(n = 39) FURSL和B组(n = 39) mini-PCNL。该研究分析了患者人口统计学、结石复杂性、手术参数、术后结果和术后结果,包括结石清除率、手术时间、住院时间、并发症发生率和恢复时间。结果:两组基线特征和手术可行性相似,mini-PCNL组SFR更高(84.62% vs 71.79%),但无统计学意义。FURSL组住院时间明显缩短(17.31±3.06 h vs 30.03±7.18 h);结论:mini-PCNL和FURSL均是治疗肾盏憩室结石的有效策略。值得注意的是,mini-PCNL提供优越的无结石率,而FURSL提供更短的手术时间,住院时间和快速恢复。
{"title":"Mini-PCNL (percutaneous nephrolithotomy) versus FURSL (flexible ureteroscopy and laser lithotripsy): A head-to-head comparison in treating calyceal diverticulum stones: A prospective randomized study.","authors":"Haitham Abdalla Shello, Mahmoud Gabril, Rehab Kamal Mahmoud, Abdelaziz Elhendawy, Omar Abdelaal","doi":"10.1177/03915603251344500","DOIUrl":"10.1177/03915603251344500","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the efficacy and safety of mini-percutaneous nephrolithotomy versus flexible ureteroscopy with laser lithotripsy in the management of calyceal diverticulum stones.</p><p><strong>Methods: </strong>The study performed a prospective analysis of 91 patients with confirmed calyceal diverticulum stones in Saudi Arabia from January 2020 to June 2024. A total of 78 patients with CD (calyceal diverticulum) stones were randomly divided into two groups: Group A (<i>n</i> = 39) FURSL and Group B (<i>n</i> = 39) mini-PCNL. The study analyzed patient demographics, stone complexity, operative parameters, postoperative results, and postoperative outcomes, including stone-free rates, operative time, hospital stay, complication rates, and recovery time.</p><p><strong>Results: </strong>Both groups showed similar baseline characteristics and surgical feasibility, with the mini-PCNL group showing a higher SFR (84.62% vs 71.79%), but not statistically significant. Hospital stay was significantly shorter in the FURSL group (17.31 ± 3.06 h vs 30.03 ± 7.18 h; <i>p</i> < 0.001). Patients undergoing FURSL returned to normal activity sooner (5.1 ± 1.37 days vs 8.03 ± 1.05 days; <i>p</i> < 0.05). Complication rates were low and nearly similar across groups.</p><p><strong>Conclusions: </strong>Both mini-PCNL and FURSL are effective strategies for treating calyceal diverticulum stones. Notably, mini-PCNL offers superior stone-free rates, while FURSL offers shorter operative times, hospital stays, and fast recovery.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"670-677"},"PeriodicalIF":0.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144561315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Partial nephrectomy is the gold standard treatment for incidentally detected small renal tumors. To optimize the outcomes, use of intra operative imaging techniques like ultrasound (IOUS), OCT (optical coherence technique) and fluorescence along with augmented reality is indicated. However, these are not available in all the centers and may also not be needed for predominantly exophytic tumors with low RENAL nephrometry scores.
Aim and objective: To evaluate the oncological outcomes and efficacy of transperitoneal laparoscopic partial nephrectomy (LPN) in patients with RENAL nephrometry score of ⩽9 without the use of IOUS.
Material and methods: This was a single centered, single surgeon, retrospective, descriptive, record-based study carried out from January 2013 till December 2018 at postgraduate department of Urology GMC Jammu with a follow up 5 years. After initial evaluation by CECT abdomen with CT renal angio the patients were subjected to transperitoneal LPN and outcomes were recorded in the patient data sheet. Demographic, intra and post op data including RENAL nephrometry score and follow up was retrieved from the patient chart after taking the due clearance from Institutional Ethics Committee.
Results: Sixty-five patients were included in the study and the average age was 52.6 ± 8 years of 40 were males and 25 were females with average BMI of 23.84 ± 5. Right sided tumors accounted for 62% of cases with upper polar 38%. Total operative time was 100 ± 20 with an average warm ischemia time of 21.55 ± 2. Average size of the tumor in our series was 4.1 ± 2 cms. One patient required blood transfusion. Surgical margins were negative in all. Average follow up in our series was 5.5 ± 1 years.
Conclusion: Transperitoneal laparoscopic partial nephrectomy for low to intermediate RENAL nephrometry score (score ⩽9) without the use of IOUS is feasible and safe with acceptable surgical and oncological outcomes on long term follow up.
{"title":"Feasibility and oncological outcome of transperitoneal laparoscopic partial nephrectomy for renal tumors with RENAL nephrometry score ⩽9 in absence of intraoperative ultrasound.","authors":"Rahul Gupta, Chetan Sharma, Yasir Mehmood, Arti Mahajan, Sunana Gupta, Kshitij Gupta, Yaser Rahman","doi":"10.1177/03915603251357641","DOIUrl":"10.1177/03915603251357641","url":null,"abstract":"<p><strong>Introduction: </strong>Partial nephrectomy is the gold standard treatment for incidentally detected small renal tumors. To optimize the outcomes, use of intra operative imaging techniques like ultrasound (IOUS), OCT (optical coherence technique) and fluorescence along with augmented reality is indicated. However, these are not available in all the centers and may also not be needed for predominantly exophytic tumors with low RENAL nephrometry scores.</p><p><strong>Aim and objective: </strong>To evaluate the oncological outcomes and efficacy of transperitoneal laparoscopic partial nephrectomy (LPN) in patients with RENAL nephrometry score of ⩽9 without the use of IOUS.</p><p><strong>Material and methods: </strong>This was a single centered, single surgeon, retrospective, descriptive, record-based study carried out from January 2013 till December 2018 at postgraduate department of Urology GMC Jammu with a follow up 5 years. After initial evaluation by CECT abdomen with CT renal angio the patients were subjected to transperitoneal LPN and outcomes were recorded in the patient data sheet. Demographic, intra and post op data including RENAL nephrometry score and follow up was retrieved from the patient chart after taking the due clearance from Institutional Ethics Committee.</p><p><strong>Results: </strong>Sixty-five patients were included in the study and the average age was 52.6 ± 8 years of 40 were males and 25 were females with average BMI of 23.84 ± 5. Right sided tumors accounted for 62% of cases with upper polar 38%. Total operative time was 100 ± 20 with an average warm ischemia time of 21.55 ± 2. Average size of the tumor in our series was 4.1 ± 2 cms. One patient required blood transfusion. Surgical margins were negative in all. Average follow up in our series was 5.5 ± 1 years.</p><p><strong>Conclusion: </strong>Transperitoneal laparoscopic partial nephrectomy for low to intermediate RENAL nephrometry score (score ⩽9) without the use of IOUS is feasible and safe with acceptable surgical and oncological outcomes on long term follow up.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"564-570"},"PeriodicalIF":0.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: This study aimed to assess the clinical outcomes of Fournier's gangrene and its predisposing factors in male diabetic and non-diabetic patients. We also evaluated the disease severity using the Fournier's Gangrene Severity Index and examined management outcomes, including mode of wound closure and complications related to the disease and treatment.
Methods: Patients with Fournier's gangrene underwent admission, with detailed history collection. Disease severity was clinically and laboratory assessed. Empirical antibiotics preceded surgical management and microbial evaluation. Wound closure involved primary suturing, skin grafting, or flaps. Patients were called for regular follow-up after discharge, and complications were identified.
Results: Our study has shown that the overall FGSI was much higher among diabetics as compared to non-diabetics, and the same goes for the mortality rate, which was much higher in diabetics, owing to the higher rate of complications among them. It was also found that the prognosis of Fournier's gangrene is worse among diabetics. The mean number of debridement's in the diabetic group (3.00 ± 1.016) was higher than the non-diabetic group (2.22 ± 1.003). The association between number of debridement's in the two groups was statistically significant (p = 0.001).
Conclusion: Early diagnosis and aggressive management are crucial to reduce Fournier's gangrene mortality. Effective diabetic control and repeated debridement are necessary to successfully manage these complex cases.
{"title":"Clinical spectrum and management of Fournier's gangrene among diabetics and non-diabetics: A comparative study.","authors":"Ashish Ranjan, Samrat Biswas, Nidhi Bhatnagar, Debabrata Kundu","doi":"10.1177/03915603251338715","DOIUrl":"10.1177/03915603251338715","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to assess the clinical outcomes of Fournier's gangrene and its predisposing factors in male diabetic and non-diabetic patients. We also evaluated the disease severity using the Fournier's Gangrene Severity Index and examined management outcomes, including mode of wound closure and complications related to the disease and treatment.</p><p><strong>Methods: </strong>Patients with Fournier's gangrene underwent admission, with detailed history collection. Disease severity was clinically and laboratory assessed. Empirical antibiotics preceded surgical management and microbial evaluation. Wound closure involved primary suturing, skin grafting, or flaps. Patients were called for regular follow-up after discharge, and complications were identified.</p><p><strong>Results: </strong>Our study has shown that the overall FGSI was much higher among diabetics as compared to non-diabetics, and the same goes for the mortality rate, which was much higher in diabetics, owing to the higher rate of complications among them. It was also found that the prognosis of Fournier's gangrene is worse among diabetics. The mean number of debridement's in the diabetic group (3.00 ± 1.016) was higher than the non-diabetic group (2.22 ± 1.003). The association between number of debridement's in the two groups was statistically significant (<i>p</i> = 0.001).</p><p><strong>Conclusion: </strong>Early diagnosis and aggressive management are crucial to reduce Fournier's gangrene mortality. Effective diabetic control and repeated debridement are necessary to successfully manage these complex cases.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"713-720"},"PeriodicalIF":0.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144086760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-05-24DOI: 10.1177/03915603251344448
Lucio Dell'Atti, Viktoria Slyusar
The purpose of this study is that the combination effects of Peyronie's disease (PD) therapy with Phosphodiesterase type 5 inhibitors (PDE5i) plus acetylsalicylic acid on improve curvature progression and pain in the active phase of disease. We performed a retrospective cohort study of 161 patients affected by PD in active stage and erectile dysfunction treated with tadalafil 5 mg once daily were divided in two groups. Group A(GA): 93 men treated with only PDE5i (tadalafil 5 mg) for 1 year or more and Group B(GB): 68 men that received tadalafil 5 mg plus aspirin 100 mg with the same protocol of GA. The patients of both groups were assessed at baseline and follow-up (6 months) for erectile function, painful erections, penile plaque size, and penile curvature. Six months after the treatment the patients in both groups had a non-significantly reduction of penile plaques. However, in GB patients had a clinically significant reduction of the curvature after 6 months by treatments 20.21° ± 7.20 versus 28.13° ± 8.11 (GA), (p < 0.001). In the analysis of our secondary endpoint, we demonstrated a significantly lower intensity of pain during erection in GB (1.43 ± 1.12) compared GA (1.89 ± 1.25; p < 0.001). We observed that the regular use of this therapeutic combination significantly provided more benefit in patients with active stage PD in terms of penile deformity, pain, and discomfort during penetrative intercourses.
{"title":"Daily phosphodiesterase type 5 inhibitors plus acetylsalicylic acid improve curvature progression and pain intensity during the active phase of peyronie's disease.","authors":"Lucio Dell'Atti, Viktoria Slyusar","doi":"10.1177/03915603251344448","DOIUrl":"10.1177/03915603251344448","url":null,"abstract":"<p><p>The purpose of this study is that the combination effects of Peyronie's disease (PD) therapy with Phosphodiesterase type 5 inhibitors (PDE5i) plus acetylsalicylic acid on improve curvature progression and pain in the active phase of disease. We performed a retrospective cohort study of 161 patients affected by PD in active stage and erectile dysfunction treated with tadalafil 5 mg once daily were divided in two groups. Group A(GA): 93 men treated with only PDE5i (tadalafil 5 mg) for 1 year or more and Group B(GB): 68 men that received tadalafil 5 mg plus aspirin 100 mg with the same protocol of GA. The patients of both groups were assessed at baseline and follow-up (6 months) for erectile function, painful erections, penile plaque size, and penile curvature. Six months after the treatment the patients in both groups had a non-significantly reduction of penile plaques. However, in GB patients had a clinically significant reduction of the curvature after 6 months by treatments 20.21° ± 7.20 versus 28.13° ± 8.11 (GA), (<i>p</i> < 0.001). In the analysis of our secondary endpoint, we demonstrated a significantly lower intensity of pain during erection in GB (1.43 ± 1.12) compared GA (1.89 ± 1.25; <i>p</i> < 0.001). We observed that the regular use of this therapeutic combination significantly provided more benefit in patients with active stage PD in terms of penile deformity, pain, and discomfort during penetrative intercourses.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"728-733"},"PeriodicalIF":0.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}